- Home
- RWT vs TSHA Comparison
RWT vs TSHA Comparison
Compare RWT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- TSHA
- Stock Information
- Founded
- RWT 1994
- TSHA 2019
- Country
- RWT United States
- TSHA United States
- Employees
- RWT N/A
- TSHA N/A
- Industry
- RWT Real Estate Investment Trusts
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- TSHA Health Care
- Exchange
- RWT Nasdaq
- TSHA Nasdaq
- Market Cap
- RWT 756.1M
- TSHA 728.4M
- IPO Year
- RWT 1995
- TSHA 2020
- Fundamental
- Price
- RWT $6.23
- TSHA $3.07
- Analyst Decision
- RWT Buy
- TSHA Strong Buy
- Analyst Count
- RWT 9
- TSHA 7
- Target Price
- RWT $7.36
- TSHA $8.71
- AVG Volume (30 Days)
- RWT 886.5K
- TSHA 3.5M
- Earning Date
- RWT 10-29-2025
- TSHA 11-12-2025
- Dividend Yield
- RWT 11.58%
- TSHA N/A
- EPS Growth
- RWT N/A
- TSHA N/A
- EPS
- RWT N/A
- TSHA N/A
- Revenue
- RWT $136,246,000.00
- TSHA $8,098,000.00
- Revenue This Year
- RWT N/A
- TSHA N/A
- Revenue Next Year
- RWT $26.89
- TSHA N/A
- P/E Ratio
- RWT N/A
- TSHA N/A
- Revenue Growth
- RWT N/A
- TSHA N/A
- 52 Week Low
- RWT $4.68
- TSHA $1.05
- 52 Week High
- RWT $8.15
- TSHA $3.40
- Technical
- Relative Strength Index (RSI)
- RWT 57.25
- TSHA 53.47
- Support Level
- RWT $6.13
- TSHA $3.16
- Resistance Level
- RWT $6.28
- TSHA $2.99
- Average True Range (ATR)
- RWT 0.12
- TSHA 0.17
- MACD
- RWT 0.01
- TSHA 0.01
- Stochastic Oscillator
- RWT 53.77
- TSHA 46.34
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.